Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Berkowitz

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factorJ A Dent, S D Berkowitz, J Ware, et al.
The American Journal of Medicine|May 31, 2001
New heparin dosing recommendations for patients with acute coronary syndromesV Menon, S D Berkowitz, E M Antman, et al.
American Heart Journal|October 20, 1998
Relation between inhibition of platelet aggregation and clinical outcomesR A Harrington, N S Kleiman, C B Granger, et al.
Blood|August 1, 1988
Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand diseaseS D Berkowitz, H Nozaki, K Titani, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical differentiation of low molecular weight heparinsH B Nader, J M Walenga, S D Berkowitz, et al.
Clinical Orthopaedics and Related Research|June 1, 1997
Hemodilution with other blood reinfusion techniques in total hip arthroplastyC S Oishi, D D D'Lima, B A Morris, et al.
Thrombosis and Haemostasis|January 1, 1997
Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study GroupJ A Heit, S D Berkowitz, R Bona, et al.
Archives of Internal Medicine|November 14, 2001
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding studyJ A Heit, C W Colwell, C W Francis, et al.
The Journal of Bone and Joint Surgery. British Volume|October 31, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programmeM R Lassen, M Gent, A K Kakkar, et al.
The Journal of Clinical Investigation|February 1, 1987
Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasminS D Berkowitz, J Dent, J Roberts, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factorJ A Dent, S D Berkowitz, J Ware, et al.
The American Journal of Medicine|May 31, 2001
New heparin dosing recommendations for patients with acute coronary syndromesV Menon, S D Berkowitz, E M Antman, et al.
American Heart Journal|October 20, 1998
Relation between inhibition of platelet aggregation and clinical outcomesR A Harrington, N S Kleiman, C B Granger, et al.
Blood|August 1, 1988
Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand diseaseS D Berkowitz, H Nozaki, K Titani, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical differentiation of low molecular weight heparinsH B Nader, J M Walenga, S D Berkowitz, et al.
Clinical Orthopaedics and Related Research|June 1, 1997
Hemodilution with other blood reinfusion techniques in total hip arthroplastyC S Oishi, D D D'Lima, B A Morris, et al.
Thrombosis and Haemostasis|January 1, 1997
Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study GroupJ A Heit, S D Berkowitz, R Bona, et al.
Archives of Internal Medicine|November 14, 2001
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding studyJ A Heit, C W Colwell, C W Francis, et al.
The Journal of Bone and Joint Surgery. British Volume|October 31, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programmeM R Lassen, M Gent, A K Kakkar, et al.
The Journal of Clinical Investigation|February 1, 1987
Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasminS D Berkowitz, J Dent, J Roberts, et al.
Pageof 5